Scholar IQ
Try ScholarIQ free
Upload Records Snowball Search Search OpenAlex
About the database
ScholarIQanswers from OpenAlex

Inhibition of SARS-CoV-2 (previously 2019-nCoV) infection by a highly potent pan-coronavirus fusion inhibitor targeting its spike protein that harbors a high capacity to mediate membrane fusion

PaperCitations, authors & open-access status

Inhibition of SARS-CoV-2 (previously 2019-nCoV) infection by a highly potent pan-coronavirus fusion inhibitor targeting its spike protein that harbors a high capacity to mediate membrane fusion is a paper indexed in ScholarIQ from OpenAlex. ScholarIQ records 1,446 citations, 2020 year and hybrid oa status.

1,446
Citations
2020
Year
hybrid
OA Status

Related on ScholarIQ

Feifei Qi
Author
SARS-CoV-2 and COVID-19 Research
Topic
SARS-CoV-2 and COVID-19 Research
Topic
interferon and immune responses
Topic
COVID-19 Clinical Research Studies
Topic
470M+ articles · free account